JAK2 V617F Mutation Detection, Bone Marrow
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Aiding in the distinction between a reactive cytosis and a chronic myeloproliferative disorder
Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
See Myeloproliferative Neoplasm: A Diagnostic Approach to Bone Marrow Evaluation in Special Instructions.
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Point Mutation Detection in DNA Using Quantitative Polymerase Chain Reaction (PCR)
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Tyrosine Kinase Mutation